• FITC-Concanavalin A (ConA) Conjugate: Technical Lab Guidance

  2026-04-23

  FITC-Concanavalin A (ConA) Conjugate enables direct and selective detection of α-D-glucose and α-D-mannose moieties on cell surfaces, supporting immunofluorescence and flow cytometry workflows in glycobiology research. It is not suitable for applications outside carbohydrate-binding detection or for use beyond its specified stability conditions.

• Technical Guide: 4-Hydroxytamoxifen in Cancer Research Workf

  2026-04-23

  4-Hydroxytamoxifen is a potent estrogen receptor modulator essential for studies involving breast and prostate cancer models, as well as cardiac myocyte signaling. It should be selected when high-purity, well-characterized reagents are needed for in vitro or in vivo experimental workflows, but is not suitable for protocols requiring aqueous or ethanol solubility.

• HyperFluor™ 488 Goat Anti-Rabbit IgG (H+L) Antibody: Technic

  2026-04-22

  HyperFluor™ 488 Goat Anti-Rabbit IgG (H+L) Antibody enables precise, high-sensitivity detection of rabbit primary antibodies in immunofluorescence and related assays. It is not suitable for primary antibodies from non-rabbit species or non-immunoglobulin targets. This guide details practical workflow integration, key parameters, and troubleshooting for robust experimental outcomes.

• Lanabecestat (AZD3293) in Alzheimer’s Research: Protocols &

  2026-04-22

  Lanabecestat (AZD3293) stands out as a next-generation, blood-brain barrier-penetrant BACE1 inhibitor, enabling precise modulation of amyloid-beta production in Alzheimer’s disease models. This article delivers actionable experimental protocols, troubleshooting insights, and evidence-backed strategies for leveraging Lanabecestat in both cellular and translational neuroscience research.

• AO/PI Staining Solution: Precision Fluorescent DNA Dye Cell

  2026-04-21

  AO/PI Staining Solution enables rapid, high-fidelity live/dead cell discrimination using advanced fluorescent DNA dyes. Its superior performance in fluorescence-based cell counting transforms viability and apoptosis assays, especially in complex samples where traditional stains fall short.

• METTL16-SENP3-LTF Axis Drives Ferroptosis Resistance in HCC

  2026-04-21

  Wang et al. identify the METTL16-SENP3-LTF axis as a critical regulator of ferroptosis resistance and tumor progression in hepatocellular carcinoma (HCC). Their findings demonstrate how m6A RNA modification and iron metabolism interplay to promote HCC survival, revealing new molecular targets for sensitizing tumors to ferroptosis-based therapies.

• Annexin V: Optimizing Apoptosis Assays with a Phosphatidylse

  2026-04-20

  Harness the power of human recombinant Annexin V for precise, early detection of apoptosis through phosphatidylserine binding. This guide delivers actionable workflow enhancements, troubleshooting insights, and comparative advantages for cell death research—grounded in recent protocol advances and APExBIO’s reagent reliability.

• Epidermal Growth Factor: Protocol Optimization and Use-Cases

  2026-04-20

  Recombinant human EGF unlocks precision in cell migration, proliferation, and mucosal healing assays. This article distills advanced workflows and troubleshooting for high-fidelity results, translating new mechanistic insights from recent studies into practical guidance for research labs.

• Remdesivir (GS-5734) Workflows: Applied Antiviral Research

  2026-04-19

  Remdesivir (GS-5734) is a gold-standard antiviral nucleoside analogue for coronavirus and filovirus research, offering precise inhibition of viral RNA synthesis in both in vitro and in vivo models. This article delivers actionable protocol enhancements, troubleshooting strategies, and cross-study insights to maximize the reliability and translational impact of Remdesivir-driven assays.

• FITC Goat Anti-Mouse IgG (H+L) Antibody: Practical Lab Guide

  2026-04-18

  The FITC Goat Anti-Mouse IgG (H+L) Antibody addresses the need for reliable, high-specificity detection of mouse IgG in immunofluorescence and flow cytometry assays. Its use is most appropriate where sensitive, fluorescence-based secondary detection of mouse primary antibodies is required; it should not be used for non-mouse targets or applications outside immunofluorescence and cytometry protocols.

• Chlorpromazine in Hepatic Pharmacology: Guiding Advanced Ant

  2026-04-17

  Explore the sophisticated roles of chlorpromazine in antipsychotic research, with a special focus on hepatic pharmacology and nanoparticle-drug interactions. This article uniquely bridges dopamine receptor signaling with liver-specific uptake, offering actionable insights for researchers.

• Mechanistic Insights into Gepotidacin and DNA Gyrase Inhibit

  2026-04-16

  This article reviews the detailed mechanistic and structural analysis of gepotidacin, a first-in-class bacterial topoisomerase inhibitor, against Staphylococcus aureus gyrase. The study elucidates how gepotidacin’s unique action and binding features distinguish it from fluoroquinolone antibiotics, providing actionable insights for antibiotic toxicity and mechanistic research.

• O-GlcNAcylation and Wnt Signaling Rewire Glycolysis in Osteo

  2026-04-15

  This study demonstrates that O-GlcNAcylation is a crucial mediator linking Wnt3a signaling to enhanced aerobic glycolysis and bone formation. By uncovering how specific post-translational modifications of metabolic regulators drive osteoblast differentiation, the research provides mechanistic insight for therapeutic strategies in osteoporosis and bone repair.

• Propidium Iodide in Cell Viability and Apoptosis Detection

  2026-04-14

  Propidium iodide (PI) is the gold-standard DNA intercalating dye for distinguishing cell viability, apoptosis, and cell cycle phases in advanced biomedical workflows. This article distills best practices, real-world troubleshooting, and key innovations—backed by reference studies and APExBIO’s rigorously validated PI—for reproducible, high-impact research.

• Dual-Action Inhibitors Promote p38α MAPK Dephosphorylation

  2026-04-13

  The referenced study reveals that certain kinase inhibitors, by stabilizing a specific inactive conformation of the p38α MAPK activation loop, accelerate dephosphorylation by the phosphatase WIP1. This dual-action mechanism not only blocks kinase activity but also promotes deactivation, providing a new strategy for designing more potent and specific therapeutic inhibitors.

451 records 14/31 page Previous Next First page 上5页 1112131415 下5页 Last page